RYTM
Rhythm Pharmaceuticals Inc
NASDAQ · Biotechnology
$103.61
-0.26 (-0.25%)
Performance
1D
—
1W
-4.94%
1M
-1.22%
3M
+3.76%
6M
+5.88%
1Y
+77.20%
YTD
-1.33%
Open$106.36
Previous Close$103.87
Day High$109.51
Day Low$102.05
52W High$122.20
52W Low$45.91
Volume1.03M
Avg Volume633.5K
Market Cap6.91B
P/E Ratio—
EPS$-3.02
SectorBiotechnology
Volume Analysis
1.63x average volume
Technical Indicators
SMA 50
$106.67
Below
SMA 200
$91.42
Above
RSI (14)
53.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-2.4% upside
Current
$103.61
$103.61
Target
$101.09
$101.09
$80.78
$101.09 avg
$123.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 142.37M | 975.71M | 873.25M |
| Net Income | -285,129,788 | -22,144,056 | -23,253,892 |
| Profit Margin | -200.3% | -2.3% | -2.7% |
| EBITDA | -286,331,037 | -26,213,634 | -24,112,007 |
| Free Cash Flow | — | -20,824,615 | -25,629,049 |
| Rev Growth | +245.7% | -2.7% | +8.2% |
| Debt/Equity | 0.67 | 0.40 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |